Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
Increased asthma severity is not only associated with enhanced recurrent hospitalization and mortality but also with higher social costs.
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113133/ |